1. Patients launch $1.27 million crowdfunding campaign for ME/CFS gut microbiome study.
    Check out the website, Facebook and Twitter. Join in donate and spread the word!
Give ME the Money
Graham McPhee spells out some of the cold, hard facts about the dismal state of ME research and politics, and has some suggestions as to what we can do about it ...
Discuss the article on the Forums.

VIP Dx MAJOR ANNOUNCEMENT on Jun 1 !

Discussion in 'XMRV Testing, Treatment and Transmission' started by parvofighter, May 31, 2010.

  1. I reckon (as Cort suggests) this move from VIPdx is linked to the CDC's upcoming meeting/annoucement.

    Cynic as I am (from experience) it would be wise for VIPdx to announce the test prematurely, to counter the inevitable fall out from the ME CFS community finding out the CDC may well be planning on brushing XMRV aside and in doing so not protecting the blood supply. Worse still not bothering to do a Replication Study at all- due to political reasons. As has happened so far 8 months since the public annoucement of XMRV in CFS. Something which is inexcusable, and repeating the CDC's history of managing 'Gay Flu'.

    Thus...............................................

    Realistic Scenario Fantasy 1:

    1) New Serology test from VIPdx, possibly 2 new? (Elisa & Western Blot).
    2) Culture test licensed for Europe @ Redlabs (Probably too much to expect more than 1 test at the moment).

    That would be pretty major as Europe hasn't got a test, and European population is 57% bigger than the USA.
    (That's a vast amount of people who need to be tested).

    Possible Scenario Fantasy 2: more than Belgium gets VIPdx/WPI XMRV technology, under license and multiple countries announced.
    E.g. Canada, Australia, Germany etc. Once that happens, the amout of patients (and familes - e.g moms) finding out they are XMRV+ (CFS, Healthy, Autistic) will hit the roof - forcing the CDC to change policy around late 2011/2012 . This may come in time and is vital in the disinformation war.

    Unrealistic Scenario Fantasy 3: VIPdx (to the irritation of the CDC) VIPdx announce CDC found XMRV in their fatigue critera CFS using WPI licensed blood tests and now publically tell CDC on their website they must now do a replication study as the public are at risk.
     
  2. Daffodil

    Daffodil Senior Member

    Messages:
    2,923
    Likes:
    895
    i know they got a new serology test in last week....so thats probably part of it...
     
  3. jimbob

    jimbob ME/CFS84-XMRV+

    Messages:
    321
    Likes:
    9
    myrtle beach, s.c.
    wooohooo!!!!!
     
  4. Frickly

    Frickly Senior Member

    Messages:
    1,046
    Likes:
    35
    Texas
    Thanks Parvo! I will be on the edge of my seat with fingers ready to type. :)
     
  5. Lelvina

    Lelvina ex-Bookworm

    Messages:
    57
    Likes:
    2
    This could be very interesting!

    All I can find:

    "March 31, 2010
    VIP Dx has received 581 specimens for XMRV testing. We continue to see 37% positivity."

    and

    "Dec 2009 – Mar 2010
    VIP Dx tested a group of 30 patients from the UK for XMRV. Of this group, 33% were positive."


    I assume that's old news, I havn't kept up with Vip Dx recently.

    EDIT: And there's a scrolling flash thing that says "As of May 7th, 2010, 701 XMRV specimens were received." I assume that's old news, too!
     
  6. Daffodil

    Daffodil Senior Member

    Messages:
    2,923
    Likes:
    895
    37%? 33%? thats kind of low, isnt it?
     
  7. Stone

    Stone Senior Member

    Messages:
    371
    Likes:
    6
    NC
    Well, what do you make of this on FB put up a few hours ago?

    Addendum
    Detection of an infectious retrovirus, XMRV, in blood cells of
    patients with chronic fatigue syndrome

    Judy A. Mikovits, Vincent C. Lombardi, Max A. Pfost, Kathryn S. Hagen
    and Francis W. Ruscetti

    Volume 1, Issue 5 Landes Bioscience Journals: Virulence
    September/October 2010

    [xga: Please note that a PDF is not available yet. Hopefully it will be epublished before the Sept publishing date]

    In October 2009, we reported the first direct isolation of infectious
    xenotropic murine leukemia virus-related virus (XMRV). In that study,
    we used a combination of biological amplification and molecular
    enhancement techniques to detect XMRV in more than 75% of 101 patients
    with chronic fatigue syndrome (CFS). Since our report, controversy
    arose after the publication of several studies that failed to detect
    XMRV infection in their CFS patient populations. In this addenda, we
    further detail the multiple detection methods we used in order to
    observe XMRV infection in our CFS cohort. Our results indicate that
    PCR from DNA of unstimulated peripheral blood mononuclear cells is the
    least sensitive method for detection of XMRV in subjects' blood. We
    advocate the use of more than one type of assay in order to determine
    the frequency of XMRV infection in patient cohorts in future studies
    of the relevance of XMRV to human disease.



    Authors
    Judy A. Mikovits
    Whittemore Peterson Institute; Reno, Nevada USA
    Vincent C. Lombardi
    Whittemore Peterson Institute; Reno, Nevada USA
    Max A. Pfost
    Whittemore Peterson Institute; Reno, Nevada USA
    Kathryn S. Hagen
    Whittemore Peterson Institute; Reno, Nevada USA
    Francis W. Ruscetti
    Laboratory of Experimental Immunology, Cancer and Inflammation
    Program; National Cancer Institute-Frederick; Frederick, MD USA

    http://www.landesbioscience.com/journals/40/article/12486/

    A PDF is not available for this article
    Updated 5 hours ago Comment Like Report Note
     
  8. julius

    julius Watchoo lookin' at?

    Messages:
    785
    Likes:
    5
    Canada
    Not really. These patients aren't carefully screened like in the Science paper. Also, the testing at VIPDX is producing a lot of false negatives.

    It does seem low at first glance, but it's actually a very promising number. Remember also that it's about 4% in the general population.
     
  9. julius

    julius Watchoo lookin' at?

    Messages:
    785
    Likes:
    5
    Canada


    Hmmmm.....it sounds like there's no single test worked out yet.

    Where's Fred....there seems to be a game afoot!!
     
  10. Funkster

    Funkster

    Messages:
    34
    Likes:
    0
    I guess VIPdx is sold to a big player...
     
  11. Knackered

    Knackered Guest

    What makes you think that?

    I can only suppose it's to announce a new test.
     
  12. Stone

    Stone Senior Member

    Messages:
    371
    Likes:
    6
    NC
    Why would the WPI need to make this statement NOW unless they were about to be refuted by another study using the "least sensitive" method? This doesn't look good to me AT ALL! I can't think of any other reason they would need to restate this point AGAIN, in a public scientific forum. Can anyone think of a positive reason for this statement? Please? And what's with the date? September/October 2010???
     
  13. Knackered

    Knackered Guest

    What statement? No one knows what they're going to announce yet, it's pointless getting yourself worked up before you even know what's going on.
     
  14. Funkster

    Funkster

    Messages:
    34
    Likes:
    0
    They have removed almost all information on their website. Only information left is the Lyme Brochure.

    Its more likely that its a company announcement and not a product announcement coming up.

    Just a guess...
     
  15. Knackered

    Knackered Guest

    The rest of the website's there: http://vipdx.com/sitemap/
     
  16. parvofighter

    parvofighter Senior Member

    Messages:
    436
    Likes:
    99
    Canada
    Serology + licencing agreement to a major player

    Dys, I loved your breakdown of scenarios. And JT, honest I'm not holding out. This is all I know!

    My guess however, is that a "Major Announcement" would be along the lines of:

    • The availability of the serology test (altho we've been expecting that)
    • A major licencing agreement by VIPDx of their new test to a major player
    • or... as was mentioned, they've been bought out by a giant - GSK? Abbott?
    OK, it's Jun 1... where's zat announcement! Oh right, normal mortals are asleep.

    Parvo:Retro smile:
     
  17. natasa778

    natasa778 Senior Member

    Messages:
    1,490
    Likes:
    1,355
    London UK
    WPI Facebook new entry

    saying just

    is :) good enough? :D:Retro smile::worried::confused:
     
  18. Rivotril

    Rivotril Senior Member

    Messages:
    154
    Likes:
    0
    hopefully this has, in some way, something to do with the CDC results that are upcoming.
    Best scenario would be, CDC found xmrv in at least healty people and don't want panic under the USA population, so they bring this news after the good news, that there is now a valid test on the market.
    Since Vipdx is the only commercial lab around to have, at this moment, the knowledge to to perform such a test, they would be the first to start with it...

    Sounds plausible in some way . but this is maybe a very very bit too much wishful thinking.....hehehe

    someone on chat came with this scenario, cant remember his name though (damn brainfog/memory :D

    But we will know within 12 hours I guess...so we don't have to speculate again for 200+ times :Retro smile:
     
  19. fred

    fred The game is afoot

    Messages:
    400
    Likes:
    1
    The four tests used by the WPI in their research studies are as follows:

    1. Serology (anti-body)
    2. Western blot of viral proteins (gag, env)
    3. Proviral DNA (infected cell) detected by PCR (DNA), RT-PCR (virion RNA)
    4. Isolation of virus in cell culture

    The WPI says that no.3 is the least reliable but this is the one that other researchers are using.

    VIP offers no.4 which is more reliable than no.3 but still produces false negatives.

    The WPI says that no.1 (serum anti-body) is the most reliable but it has not been available commercially to date. VIP may announce the availability of the test this week.

    In the Spanish presentation, De Meirleir said that a reliable test will be available in Europe within days (although this was qualified as 3-4 weeks by someone else). He did not clarify if this was anti-body or another type of test.

    There have been rumours of Abbott Diagnostics getting to close to launching an anti-body test but I do not know whether this is related to VIP, DeMeirleir or both or neither.

    Further rumours have suggested that certain 'replication' researchers are waiting for the anti-body test to come available because they are finding it very hard to isolate XMRV using PCR. If this is the case, we may see a growing number of positive replication studies once the anti-body test becomes available.
     
  20. Adam

    Adam *****

    Messages:
    495
    Likes:
    1
    Sheffield UK
    Thanks Fred for the digest of recent events re testing procedures. I never remember more than 2 tests at any one time. :confused:

    I propose we should call you King of the Rumour Mill! :innocent1:

    I love the way you feed us these tid bits of intrigue. ;)
     

See more popular forum discussions.

Share This Page